Status:
UNKNOWN
Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma
Lead Sponsor:
Medical University of Vienna
Conditions:
Uveal Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the safety and efficacy of hypofractionated stereotactic LINAC radiotherapy with 10 fractions at 6 Gy per fraction at the 80% isodose for the planning target vol...
Eligibility Criteria
Inclusion
- The initial height of the melanoma is 7 mm or higher.
- Juxtapapillary and/or juxtamacular melanomas with a height of 3 mm or higher and if the central tumor distance to the optic disc and/or the macula is 3 mm or less.
- If other forms of conservative treatment of the melanoma are not possible.
Exclusion
- Prior/Concomitant Treatment.
- Extrascleral tumor extension is present.
- If the presence of neovascular glaucoma is detected before treatment.
- If metastasis is detected at baseline.
- Previous participation in any study of investigational drugs within 3 month preceding day 0.
- Pregnant women are not allowed to participate in the study.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00872391
Start Date
March 1 2009
Last Update
March 31 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology and the Department of Radiotherapy and Radiobiology, Medical University of Vienna
Vienna, Vienna, Austria, 1090